Table 2. The change of major indicators after treatment with triclabendazole.
Item | SN | Indicator | Proportion of abnormal measurement | P-value | |||
Before | After | ||||||
Biochemical indicators | |||||||
1 | A/G | 0.98 | 0.70 | 0.00 | |||
2 | CRP | 0.97 | 0.04 | 0.00 | |||
3 | GGT | 0.95 | 0.52 | 0.00 | |||
4 | ALP | 0.83 | 0.22 | 0.00 | |||
5 | GLO | 0.80 | 0.87 | 0.63 | |||
6 | ALB | 0.75 | 0.00 | 0.00 | |||
7 | CK | 0.75 | 0.00 | 0.00 | |||
8 | CHE | 0.67 | 0.00 | 0.00 | |||
9 | LDH | 0.62 | 0.39 | 0.04 | |||
10 | HBDH | 0.56 | 0.39 | 0.16 | |||
11 | ALT | 0.50 | 0.13 | 0.00 | |||
12 | AST | 0.37 | 0.04 | 0.00 | |||
13 | TBA | 0.28 | 0.09 | 0.05 | |||
14 | D-BIL | 0.17 | 0.00 | 0.06 | |||
Cellular indicators | |||||||
1 | EO% | 0.96 | 0.96 | 0.69 | |||
2 | EO# | 0.95 | 0.87 | 0.34 | |||
3 | HGB | 0.89 | 0.09 | 0.00 | |||
4 | HCT | 0.89 | 0.13 | 0.00 | |||
5 | R-SD | 0.76 | 0.87 | 0.26 | |||
6 | RBC | 0.75 | 0.13 | 0.00 | |||
7 | R-CV | 0.69 | 0.61 | 0.41 | |||
8 | WBC | 0.65 | 0.09 | 0.00 | |||
9 | PLT | 0.55 | 0.00 | 0.00 |
% and # denote the proportion and absolute count, respectively.